Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.63 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.